REFERENCES
1. Li JY, Liu BQ, Li GY, Chen ZJ, Sun XI, Rong SD. Atlas of cancer mortality in the People's Republic of China. An aid for cancer control and research. Int J Epidemiol 1981;10:127-33.
2. Chen JG, Zhu J, Parkin DM, Zhang YH, Lu JH, Zhu YR, Chen TY. Trends in the incidence of cancer in Qidong, China, 1978-2002. Int J Cancer 2006;119:1447-54.
3. Lu JH, Li WG, Jiang ZY, Ni ZP, Huang F. Prospective survey on relationship between HBsAg carrier status and liver cancer. J Med Res 1983;(5):13-4.
4. Wei YP, Lu PX, Huang QS, Lu SX, Zhang QN, Gu JP. Prospective study with 518 participants on relationship between HBsAg status and liver cancer incidence. J Clin Hepatol 1992;8:77-8.
5. Wang YB, Lan LZ, Ye BF, Xu YC, Li WG. Study on relationship between geographical distribution of liver cancer, climate and aflatoxin B1. Tumor 1981;1:1-5.
6. Li WG, Xie JR, Yu SY, Chu YJ, Gong XL. Relationship between geographic distribution of primary liver cancer and selenium level in Qidong county. Trace Elements 1986;(3):58-61.
7. Liu PL, Su DL, Yu SZ, Li WG. HBV seroepidemiological study in population with different drinking water sources in Qidong county. Acta Acad Med Prim Shanghai 1985;12:427-34.
8. Chen JG. Liver cancer endemic trend between 1972 and 1981 in Qidong county. J Med Res 1983;(12):13-5.
9. Yang L, Parkin DM, Whelan S, Zhang S, Chen Y, Lu F, Li L. Statistics on cancer in China: cancer registration in 2002. Eur J Cancer Prev 2005;14:329-35.
10. Sun GJ, He X, Qian GS, Pu YP, Jin XP, Wang JS. Detecting urine aflatoxin metabolism by high performance liquid chromatography. J Health Toxicol 2000;14:250-2.
11. Sun GJ, He X, Qian GS, Pu YP, Jin XP, Wang JS. Detection of aflatoxin-ablumin adducts in human serum and its application. Wei Sheng Yan Jiu 2001;30:185-7. (in Chinese)
12. Wu YQ, Wan SG, Lu PX, Wang JS, Kuang SY, Wang JB, Fang X, Wu Y, Zhang QN, Qu Q, Kensler T, Groopman J, Qian GS. Genotype of GSTT1 and GSTM1 among population in Qidong liver cancer high incidence field. Natl Med J China 1999;79:517-8.
13. Wu YQ, Lu PX, Wang JS, Wang JB, Wan SG, Kensler TW, Groopman JD, Qian GS. Correlation between the genetic polymorphism of EPHX and susceptibility to hepatocellular carcinoma. Tumor 2003;23:287-9.
14. Xu L, Wu YQ, Jin Y, Yu YM, Qian GS. A case-control study on polymorphism of DNA repair gene XPD and susceptibility to hepatocellular carcinoma. Tumor 2004;24:526-9.
15. Qian GS, Kuang SY, He X, Groopman JD, Jackson PE. Sensitivity of electrospray ionization mass spectrometry detection of codon 249 mutations in the p53 gene compared with RFLP. Cancer Epidemiol Biomarkers Prev 2002;11:1126-9.
16. Kuang SY, Jackson PE, Wang JB, Lu PX, Mu-oz A, Qian GS, Kensler TW, Groopman JD. Specific mutations of hepatitis B virus in plasma predict liver cancer development. Proc Natl Acad Sci U S A 2004;101:3575-80.
17. Guo X, Jin Y, Qian GS, Xu L, Tu H. Full-genome sequence analysis of hepatitis B virus isolated from hepatocellular carcinoma in high incidence area Qidong. Tumor 2007;27:429-32.
18. Bai X, Zhu Y, Jin Y, Guo X, Qian G, Chen T, Zhang J, Wang J, Groopman JD, Gu J, Tu H. Temporal acquisition of sequential mutations in the enhancer II and basal core promoter of HBV in individuals at high risk for hepatocellular carcinoma. Carcinogenesis 2011;32:63-8.
19. Guo X, Jin Y, Qian G, Tu H. Sequential accumulation of the mutations in core promoter of hepatitis B virus is associated with the development of hepatocellular carcinoma in Qidong, China. J Hepatol 2008;49:718-25.
20. Bai X, Zhu Y, Jin Y, Cai X, Guo X, Qian G, Chen T, Zhang J, Wang J, Tu H. Correlation of the mutations in N terminal of hepatitis B virus X protein with tumorigenesis of hepatocellular carcinoma. Tumor 2010;30:433-7.
21. Cao Z, Bai X, Guo X, Jin Y, Qian G, Tu H. High prevalence of hepatitis B virus pre-S mutation and its association with hepatocellular carcinoma in Qidong, China. Arch Virol 2008;153:1807-12.
22. Zhu Y, Jin Y, Cai X, Bai X, Chen M, Chen T, Wang J, Qian G, Gu J, Li J, Tu H. Hepatitis B virus core protein variations differ in tumor and adjacent nontumor tissues from patients with hepatocellular carcinoma. Intervirology 2012;55:29-35.
23. Zhu Y, Jin Y, Guo X, Bai X, Chen T, Wang J, Qian G, Groopman JD, Gu J, Li J, Tu H. Comparison study on the complete sequence of hepatitis B virus identifies new mutations in core gene associated with hepatocellular carcinoma. Cancer Epidemiol Biomarkers Prev 2010;19:2623-30.
24. Wu Y, Gan Y, Gao F, Zhao Z, Jin Y, Zhu Y, Sun Z, Wu H, Chen T, Wang J, Sun Y, Fan C, Xiang Y, Qian G, Groopman JD, Gu J, Tu H. Novel natural mutations in the Hepatitis B Virus reverse transcriptase domain associated with hepatocellular carcinoma. PLoS One 2014;9:1-10.
25. Gao FM, Wu Y, Zhao ZM, Jin Y, Qian GS, Chen TY, Zhang YW, Wang JB, Gan Y, Xiang YB, Tu H. The association between mutations in the reverse transcriptase domain of hepatitis B virus polymerase gene with tumorigenesis of hepatocellular carcinoma. Tumor 2014;34:141-6.
26. Zhao ZM, Zhu Y, Wu Y, Fan CS, Chen TY, Gan Y, Tu H. Development and application of a reverse hybridization method for detection of hepatitis B virus precore mutation associated with hepatocellular carcinoma. China Oncol 2014;24:266-72.
27. Zhao ZM, Jin Y, Gan Y, Zhu Y, Chen TY, Wang JB, Sun Y, Cao ZG, Qian GS, Tu H. Novel approach to identifying the hepatitis B virus pre-S deletions associated with hepatocellular carcinoma. World J Gastroenterol 2014;20:13573-81.
28. Lu P, Kuang S, Wang J, Fang X, Zhang Q, Wu Y, Lu Z, Qian G. Hepatitis B virus infection and aflatoxin exposure in the development of primary liver cancer. Natl Med J China 1998;78:340-2.
29. Lu P, Zhang Q, Huang Q, Wei Y. The HBV and HCV infection rates among various populations in high incidence area of hepatocellular carcinoma (HCC) and their relationship with HCC. Tianjin Med J 1999;27:6-7.
30. Lu P, Wang J, Wu Y, Zhang Q, Wu Y, Wan S, Kuang S, Wang N, Qian G. Significance of prospective follow-up cohort study in diagnosis and treatment of primary hepatic cancer among HBsAg carriers. Natl Med J China 2001;81:856-9.
31. Sun Y, Lu P, Wang J, Wu Y, Zhang Q, Chen T. A prospective study of the relationship between hepatitis B virus markers and primary liver cancer. Tianjin Med J 2010;38:81-3.
32. Sun Y, Chen T, Lu P, Wang J, Wu Y, Zhang Q, Jin Y, Qian G, Tu H. A seventeen-year prospective cohort study on association of hepatitis B virus e antigen with the risk of hepatocellular carcinoma. Tumor 2011;31:841-5.
33. Sun Y, Chen T, Lu P, Wang J, Wu Y, Zhang Q, Qian G, Tu H. Relationship between serum hepatitis B virus DNA load and hepatocellular carcinoma in Qidong, China: a cohort follow-up study of 14 years. Natl Med J China 2012;92:1874-7.
34. Iloeje UH, Yang HI, Chen CJ. Natural history of chronic hepatitis B: what exactly has REVEAL revealed? Liver Int 2012;32:1333-41.
35. Liu TT, Fang Y, Xiong H, Chen TY, Ni ZP, Luo JF, Zhao NQ, Shen XZ. A case-control study of the relationship between hepatitis B virus DNA level and risk of hepatocellular carcinoma in Qidong, China. World J Gastroenterol 2008;14:3059-63.
36. Liu S, Zhang H, Gu C, Yin J, He Y, Xie J, Cao G. Associations between hepatitis B virus mutations and the risk of hepatocellular carcinoma: a meta-analysis. J Natl Cancer Inst 2009;101:1066-82.
37. Qian GS, Ross RK, Yu MC, Yuan JM, Gao YT, Henderson BE, Woqan GN, Groopman JD. A follow-up study of urinary markers of aflatoxin exposure and liver cancer risk in Shanghai, People's Republic of China. Cancer Epidemiol Biomarkers Prev 1994;3:3-10.
38. Lu P, Wang J, Zhang Q, Wu Y, Sun Y, Chen T. Longitudinal study of aflatoxin exposure in the development of primary liver cancer in patients with chronic hepatitis. Natl Med J China 2010;90:1665-9.
39. Jackson PE, Qian GS, Friesen MD, Zhu YR, Lu P, Wang JB, Wu Y, Kensler TW, Vogelstein B, Groopman JD. Specific p53 mutations detected in plasma and tumors of hepatocellular carcinoma patients by electrospray ionization mass spectrometry. Cancer Res 2001;61:33-5.
40. Luo H, Wan S, Lu P, Liu Y, Wang J, Jin Y, Wu Y, Qian G. The p53 overexpression in Qidong liver cancer tissues analysed immunohistochemically. Tumor 2002;22:101-3.
41. Rashid A, Wang JS, Qian GS, Lu BX, Hamilton SR, Groopman JD. Genetic alterations in hepatocellular carcinomas: association between loss of chromosome 4q and p53 gene mutations. Br J Cancer 1999;80:59-66.
42. Jackson PE, Kuang SY, Wang JB, Strickland PT, Mu-oz A, Kensler TW, Qian GS, Groopman JD. Prospective detection of codon 249 mutations in plasma of hepatocellular carcinoma patients. Carcinogenesis 2003;24:1657-63.
